- AdventHealth
Narendra Dereddy, MD, was appointed to the Board of Directors of the Florida Birth-Related Neurological Injury Compensation Association (NICA) and will serve as the Florida representative of hospitals.
Dereddy currently serves as the medical director for neonatology, the neonatal intensive care unit, and pediatric care transformation at AdventHealth.
Created by Florida legislature in response to the malpractice insurance crisis where obstetricians were reluctant to treat high risk pregnancies, NICA is responsible for providing medically necessary help to infants affected by catastrophic birth-related neurologic injuries. The statutory organization manages state funds collected from participating physicians and hospitals to provide appropriate medical care and assistance to these infants and their families.
“As a neonatal-perinatal medicine specialist, I have cared for hundreds of infants affected by various birth related neurologic injuries and wanted to serve on the NICA board to advocate for these vulnerable infants and support preventive measures to decrease the incidence of birth-related neurologic injuries,” Dereddy said.
Dereddy attended medical school at Banaras Hindu University in India and completed his residency and fellowship at Maria Fareri Children’s Hospital at Westchester Medical Center at New York Medical College. Additionally, he is a member of the American Academy of Pediatrics.
Dereddy is one of several AdventHealth clinical leaders who have been recently appointed to a statewide post. He will serve in this position through August 2024.
Recent News
2026 APP Symposium
to ET
Antibiotic Prophylaxis for Peroral Cholangioscopy: Systematic Review Examines Postprocedural Cholangitis Risk
A new study from AdventHealth physicians published in Gastrointestinal Endoscopy examines the use of antibiotic prophylaxis before peroral cholangioscopy.
Taking a Whole-Person Care Approach to Seroma Prevention in Breast Reconstruction
Preventing seroma isn't solely the responsibility of the reconstructive surgeon; it requires a coordinated team committed to whole-person care.
The New Era of Multiple Myeloma Care: How Immunotherapy is Redefining What’s Possible
Advances in immunotherapy, precision diagnostics and cellular therapies are redefining what’s possible in multiple myeloma care.
AdventHealth Researcher Selected as NIH Rising Star for His Work on How Exercise Transforms Human Adipose Tissue
AdventHealth Translational Research Institute (TRI) researcher Dr. Cheehoon Ahn explores potential benefits of exercise within adipose (fat) tissue.
Expanding the Treatment Toolbox for Platinum-Resistant Ovarian Cancer
The landscape for platinum-resistant ovarian cancer (PROC) is evolving, offering new hope through targeted therapies, immunotherapy and clinical research.
Moving Toward Precision Medicine for HPV+ Oropharyngeal Cancers
Improved molecular diagnostics represents the next frontier in head and neck oncology.
Magnetoencephalography (MEG): Improving Patient Care Through Advanced Non-Invasive Brain Mapping
From preserving brain function and reducing reliance on invasive procedures, magnetoencephalography (MEG) expands what’s possible in neurological care.
Improving Care of Patients with Down Syndrome: The Clinical Impact of an Integrated Lifespan Model
What happens when care for pediatric and adult patients with Down syndrome is connected in one place?
MRI-Guided Ultrasound Ablation Offers a Middle Ground in Prostate Cancer Care
Deferring prostate cancer treatment can help preserve urinary and sexual functions but introduces the psychological burden of living with a known cancer.
Advancing Metabolic Health Through Coordinated Care
The Metabolic Health Institute is a first-of-its-kind model unifying endocrinology, obesity medicine and bariatric surgery under non-surgical leadership.
Strengthening Aortic Aneurysm Screening Strategies to Save More Lives
AdventHealth Director of Aortic Surgery Ioannis Loumiotis, MD, shares how strengthening screening strategies can help identify aortic disease earlier.